
EveryONE Medicines Appoints New CEO and Chairman
Key Highlights
- Kent Rogers appointed as CEO and Josh Ofman, MD, MSHS as Chairman.
- First biotech company dedicated to personalized genetic medicines.
- Focus on antisense oligonucleotides (ASOs) for rare neurological diseases.
- Initial support from regulatory authorities for new therapy pathways.
- Founded with backing from Khosla Ventures, GV, and Third Rock Ventures.
Source: Business Wire
Notable Quotes
Expert Insights
Share Your Expert Insights
Have relevant experience or professional perspective? Add your thoughtful insights to this article.


